Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.
King LDW. et al, (2024), Cell reports. Medicine, 5
Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies.
Ko K-T. et al, (2022), Nat Commun, 13
Functional Characterization and Comparison of Plasmodium falciparum Proteins as Targets of Transmission-blocking Antibodies.
Nikolaeva D. et al, (2020), Molecular & cellular proteomics : MCP, 19, 155 - 166
A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response
Marini A. et al, (2019), Frontiers in Immunology, 10
Production and characterisation of the first human monoclonal antibodies against Plasmodium falciparum transmission blocking antigen Pfs25
Zaric M. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1683 - 1684
DEMONSTRATION OF A BLOOD-STAGE CONTROLLED HUMAN MALARIA INFECTION MODEL FOR PLASMODIUM VIVAX VACCINE EFFICACY TESTING
Minassian AM. et al, (2019), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 101, 133 - 134
PLUG AND DISPLAY VIRUS-LIKE-PARTICLE VACCINES FOR OUTBREAK PATHOGENS
Taylor IJ. et al, (2019), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 101, 263 - 263
Combination of RTS,S and Pfs25-IMX313 Induces a Functional Antibody Response Against Malaria Infection and Transmission in Mice
Brod F. et al, (2018), Frontiers in Immunology, 9
Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model
Yoshida K. et al, (2018), Scientific Reports, 8
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
Lennartz F. et al, (2018), Nature Communications, 9
Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines
Menon V. et al, (2018), Frontiers in Immunology, 8
CHARACTERIZING THE IMMUNE RESPONSE TO RIFT VALLEY FEVER VIRUS IN MULTIPLE SPECIES AFTER NATURAL EXPOSURE OR VACCINATION WITH CHADOX1-RVF
Wright D. et al, (2018), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99, 424 - 424
INVESTIGATION OF TWO VACCINE-DELIVERY PLATFORMS TO ENHANCE IMMUNOGENICITY AND TRANSMISSION-BLOCKING ACTIVITY OF MALARIA VACCINE CANDIDATE PVS25
Marini A. et al, (2018), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99, 584 - 584
PLUG AND DISPLAY VIRUS-LIKE-PARTICLE VACCINES FOR OUTBREAK PATHOGENS
Taylor I. et al, (2018), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99, 75 - 75
Evaluation of two lead malaria transmission blocking vaccine candidate antibodies in natural parasite-vector combinations
Bompard A. et al, (2017), Scientific Reports, 7
Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines
Leneghan DB. et al, (2017), Scientific Reports, 7
Role of Activins in Hepcidin Regulation during Malaria
Spottiswoode N. et al, (2017), Infection and Immunity, 85